Skip to content

What are the visual symptoms of amyloidosis?

4 min read

While vision problems can arise from many different conditions, the accumulation of abnormal proteins known as amyloid can lead to specific and sometimes unusual visual symptoms of amyloidosis. Understanding these signs is crucial, as they may be the first indication of a larger systemic issue that requires medical attention.

Quick Summary

The visual symptoms of amyloidosis can vary depending on which part of the eye is affected by amyloid deposits, leading to issues like floaters and cloudy vision from vitreous opacities, droopy eyelids (ptosis) from deposits in the surrounding tissues, or 'raccoon eyes' from fragile blood vessels.

Key Points

  • Raccoon Eyes: Periorbital bruising, especially after minor trauma, is a classic sign of systemic AL amyloidosis due to fragile blood vessels.

  • Vitreous Floaters and Opacities: "Glass wool" or "cobweb"-like floaters in the vision are common in hereditary (hATTR) amyloidosis, caused by protein deposits in the vitreous gel.

  • Droopy Eyelids (Ptosis): Amyloid buildup can weaken the eyelid muscles, causing one or both eyelids to droop, obstructing vision.

  • Corneal Dystrophies: Amyloid can form lattice-like lines or nodules on the cornea, leading to pain, light sensitivity, and impaired vision.

  • Dry Eye and Irritation: Damage to nerves or lacrimal glands can cause persistent dryness and irritation, often affecting those with hereditary amyloidosis.

  • Secondary Glaucoma: Deposits in the eye's drainage system can increase intraocular pressure, potentially damaging the optic nerve and causing glaucoma.

  • Early Detection is Crucial: Because symptoms can be subtle and mimic other conditions, early ophthalmological examination followed by a systemic workup is key for timely diagnosis and management.

In This Article

Understanding Amyloidosis and its Ocular Impact

Amyloidosis is a group of rare diseases characterized by the buildup of abnormal protein fibers called amyloid in organs and tissues. When these protein deposits accumulate in or around the eyes, it is known as ocular amyloidosis. This can occur as a localized issue affecting only the eyes, or as a manifestation of systemic amyloidosis, where deposits affect multiple organs throughout the body. The specific visual symptoms and their severity depend heavily on which ocular structures are infiltrated by the amyloid proteins.

Symptoms Affecting the Eyelids and Surrounding Areas

The amyloid buildup can occur in the structures surrounding the eyeball, known as the ocular adnexa and orbit. These symptoms can be quite distinct and often signal systemic involvement.

  • Periorbital Bruising (Raccoon Eyes): A classic and often tell-tale sign of systemic amyloidosis, particularly AL amyloidosis, is spontaneous bruising and purplish discoloration around the eyelids. This occurs due to increased fragility of blood vessels infiltrated with amyloid. Minor trauma, or even no trauma at all, can trigger this distinctive bruising.
  • Droopy Eyelids (Ptosis): Amyloid deposits in the levator palpebrae muscle, which controls eyelid movement, can cause one or both eyelids to droop.
  • Waxy, Rubbery Nodules: Firm, waxy-looking nodules or lesions may develop on the eyelids or conjunctiva (the membrane lining the inside of the eyelids and covering the white of the eye). These can range from yellowish to pinkish in color.

Visual Disturbances from Inside the Eye

When amyloid infiltrates the internal structures of the eye, it can lead to more direct and significant vision impairment.

  • Vitreous Opacities: The vitreous is the clear, gel-like substance that fills the eye. Amyloid deposits here are a hallmark of hereditary amyloidosis and can cause floaters, blurred or cloudy vision, and glare. These opacities are often described as having a "glass wool," "cobweb," or "string of pearls" appearance. As the deposits increase, vision may progressively worsen.
  • Corneal Dystrophies: Amyloid buildup in the cornea (the clear front surface of the eye) can cause various dystrophies. For instance, lattice corneal dystrophy results in the formation of branching, lattice-like lines within the cornea, causing vision problems, light sensitivity, and pain. Another form, gelatinous drop-like dystrophy, causes mulberry-like nodules on the corneal surface.
  • Glaucoma: Amyloid deposits can also infiltrate the iris and the eye's drainage system (trabecular meshwork), leading to an increase in intraocular pressure (IOP) and a type of glaucoma. This can cause optic nerve damage and potentially permanent vision loss if left untreated.

Other Notable Ocular Symptoms

Beyond the most common manifestations, amyloidosis can present with other notable visual signs.

  • Scalloped Pupils: Amyloid deposits can accumulate around the pupillary margin, causing the border of the pupil to appear uneven or wavy. This is particularly associated with certain hereditary forms of amyloidosis.
  • Dry Eye Syndrome: Nerve damage or infiltration of the lacrimal glands can disrupt tear production, leading to persistent eye irritation, dryness, and a gritty sensation.
  • Double Vision (Diplopia): Amyloid deposits affecting the extraocular muscles responsible for eye movement can lead to double vision, or issues with the coordination of eye movements.
  • Progressive Visual Impairment: Overall, vision often declines gradually and progressively as the amyloid deposits accumulate. Patients may experience reduced contrast sensitivity, visual distortions, or shadows in their visual field.

Visual Symptoms by Amyloidosis Type

The visual symptoms and their frequency can differ based on the type of amyloidosis. A comparative understanding can aid in diagnosis.

Comparison of Ocular Symptoms by Amyloidosis Type

Feature Hereditary (hATTR) Amyloidosis Systemic AL Amyloidosis Localized Amyloidosis
Primary Ocular Site Vitreous humor and retina Eyelids, orbit, and conjunctiva Cornea and conjunctiva
Classic Symptoms Vitreous opacities, floaters, cloudy vision Periorbital purpura ('raccoon eyes'), waxy eyelid lesions Corneal dystrophies (lattice/gelatinous), conjunctival masses
Glaucoma Risk Significant, especially with TTR mutations Lower incidence; related to tissue infiltration Can occur if drainage is affected
Dry Eye Common due to autonomic neuropathy Less frequently reported Varies depending on location of deposits

The Role of Early Diagnosis and Monitoring

Because many visual symptoms of amyloidosis are nonspecific and can mimic other eye conditions, an early and accurate diagnosis is critical. An eye care professional may be the first to spot signs, which should then prompt a systemic evaluation. If amyloidosis is already diagnosed, regular and thorough eye monitoring is essential, particularly for hereditary forms like hATTR amyloidosis. The amyloid deposits can continue to accumulate even after systemic treatment, potentially requiring eye-specific interventions like a vitrectomy to remove vision-obstructing deposits. A comprehensive approach involving ophthalmologists and specialists in other affected areas of the body is often necessary for effective long-term management.

Conclusion: Recognizing the Signs for Better Outcomes

Amyloidosis can affect nearly every part of the eye, from the surrounding eyelids to the internal vitreous and retina. Recognizing the diverse range of visual symptoms, including the characteristic periorbital bruising, vitreous opacities, and specific corneal dystrophies, is vital for early diagnosis and appropriate management. If you or a loved one experience any unusual or persistent visual changes, consulting a healthcare provider is the most important step towards understanding the cause and protecting your health. For more general information on amyloidosis, visit the official website of the Amyloidosis Foundation.

Seeking medical advice for amyloidosis

Due to the complexity of amyloidosis and its impact on vision, it is essential to consult with both an ophthalmologist and a specialist in amyloidosis for accurate diagnosis and tailored treatment. This multi-specialty approach ensures that both the ocular symptoms and the underlying systemic condition are addressed effectively.

Frequently Asked Questions

Yes, ocular symptoms can sometimes be the first or only signs of amyloidosis, particularly in hereditary forms like hATTR amyloidosis. This is why any unusual or unexplained visual changes should be investigated by a doctor.

Not necessarily. While some vision issues can recur or progress, some conditions, like vision-obscuring vitreous opacities, can be treated surgically with a vitrectomy to restore clarity. Treatments for dry eye can also provide symptomatic relief.

Periorbital purpura, or 'raccoon eyes,' is a classic sign of systemic AL amyloidosis, caused by extremely fragile blood vessels around the eyes. Its presence often warrants a full systemic evaluation for amyloidosis.

Significant vitreous opacities that impair vision are often treated with a pars plana vitrectomy. This surgical procedure removes the amyloid-filled vitreous gel and replaces it, which can significantly improve vision.

While localized ocular amyloidosis primarily affects the eye, it is essential to undergo systemic screening. It is known that what appears to be localized amyloidosis may sometimes progress or be an early sign of systemic disease.

Yes, dry eye syndrome is a common symptom in patients with hereditary transthyretin (hATTR) amyloidosis. It is often a result of damage to the autonomic nerves that control tear production or infiltration of the lacrimal glands.

A 'scalloped pupil' is a condition where the border of the pupil appears wavy or uneven. It is a sign of iris infiltration by amyloid deposits and is sometimes associated with hereditary amyloidosis and glaucoma.

Yes, it is highly recommended. Ocular symptoms can be the presenting feature of a systemic disease, so a full medical evaluation is crucial to determine if other organs are affected and to ensure proper management.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.